Folate-targeted therapies for cancer.
Xia
Wei
W
Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, Indiana 47907, USA.
Low
Philip S
PS
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology / Q000627:therapeutic use; D002352:Carrier Proteins / Q000096:biosynthesis; D004337:Drug Carriers; D058973:Folate Receptors, GPI-Anchored; D005492:Folic Acid / Q000378:metabolism*; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D008024:Ligands; D053758:Nanoparticles; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism* / Q000628:therapy; D020320:Oligoribonucleotides, Antisense / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D034741:RNA, Small Interfering / Q000494:pharmacology; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000737:chemistry / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000096:biosynthesis; D015854:Up-Regulation
D000970:Antineoplastic Agents; D002352:Carrier Proteins; D004337:Drug Carriers; D058973:Folate Receptors, GPI-Anchored; D008024:Ligands; D020320:Oligoribonucleotides, Antisense; D034741:RNA, Small Interfering; D019275:Radiopharmaceuticals; D011956:Receptors, Cell Surface; D005492:Folic Acid